Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Position in ORIC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$687,379
+$172 QoQ
Shares Held
63,470
+17.0% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 179 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority Sole 40% Shared 0% None 60%

Common Shares in ORIC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ORIC ranks #127 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORIC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $687,379 63,470
2026-03-31 $687,207 54,239
2025-12-31 $415,396 50,782
2025-09-30 $278,820 23,235
2025-03-31 $2,841,218 509,179
2024-12-31 $287,122 35,579
2024-09-30 $236,098 23,034
2024-06-30 $299,202 42,320
2022-03-31 $69,596 13,033
2021-12-31 $191,584 13,033
2021-09-30 $272,519 13,033
2021-06-30 $230,552 13,033
2021-03-31 $269,500 11,000
2020-12-31 $250,490 7,400
2020-06-30 $430,900 12,775